Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04425876
What this trial is testing

Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 74
Testing effectiveness (Phase 2)Looking for participantsNCT05913674
What this trial is testing

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

Who this might be right for
Peritoneal CarcinomatosisAppendiceal NeoplasmsColorectal Cancer Metastatic
Ciusss de L'Est de l'Île de Montréal 25
Not applicableStudy completedNCT07147374
What this trial is testing

Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyRobotic Surgery
Peking Union Medical College Hospital 56
Testing effectiveness (Phase 2)Study completedNCT04705818
What this trial is testing

Combining Epigenetic And Immune Therapy to Beat Cancer.

Who this might be right for
Advanced Solid TumorAdvanced Colorectal CarcinomaAdvanced Soft-tissue Sarcoma+2 more
Institut Bergonié 164
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Post-approval studies (Phase 4)Study completedNCT02581423
What this trial is testing

Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 63
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Not applicableStudy completedNCT02547480
What this trial is testing

LifePearl-Iri Pharmacokinetic Study

Who this might be right for
Metastatic Colorectal CancermCRC
Terumo Europe N.V. 15
Not applicableStudy completedNCT06271980
What this trial is testing

Early-Onset Colorectal Cancer Recurrence

Who this might be right for
Colorectal Cancer RecurrentColorectal CancerColorectal Neoplasms+4 more
City of Hope Medical Center 177
Testing effectiveness (Phase 2)UnknownNCT05795296
What this trial is testing

Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer

Who this might be right for
Stomach Neoplasms
RenJi Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02941562
What this trial is testing

A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT

Who this might be right for
Rectal Cancer, Radiotherapy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150
Not applicableStudy completedNCT01234246
What this trial is testing

Sexual Dysfunction and the Quality of Sexual Life in Patients With Colorectal Cancer and Their Partners.

Who this might be right for
Colorectal Cancer Patients and Their Partners
Tilburg University 1,371
Testing effectiveness (Phase 2)Study completedNCT02829918
What this trial is testing

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerBiliary Tract Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 54
Not applicableUnknownNCT01726010
What this trial is testing

22-G-Procore Needle for the Diagnosis of SETs of the Upper GI Tract

Who this might be right for
Subepithelial Tumors of the Upper Gastrointestinal Tract
Technical University of Munich 20
Testing effectiveness (Phase 2)Study completedNCT03609424
What this trial is testing

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 39
Not applicableStudy completedNCT03907579
What this trial is testing

Screen to Save: A Colorectal Cancer Educational Intervention

Who this might be right for
Colorectal Cancer
Dartmouth-Hitchcock Medical Center 100
Not applicableStudy completedNCT03485196
What this trial is testing

The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation

Who this might be right for
Gastric Cancer
Affiliated Hospital of Qinghai University 1,000
Not applicableUnknownNCT00654342
What this trial is testing

Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer

Who this might be right for
Sentinel Lymph Node BiopsyColon Cancer
Chung-Ang University 100
Testing effectiveness (Phase 2)Ended earlyNCT00766142
What this trial is testing

Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

Who this might be right for
Colorectal CancerPrimary Peritoneal Cavity Cancer
Institut Bergonié 18
Not applicableAvailableNCT07689942
What this trial is testing

Expanded Access to 0.5 mg eRapa for Familial Adenomatous Polyposis

Who this might be right for
Familial Adenomatous Polyposis (FAP)
Biodexa Pharmaceuticals
Next Page